Technical Articles

Why P53 has driven four decades of drug discovery yet remains unsolved, and how standardized recombinant P53 reagents support target validation, screening and mechanistic studies across the industry.

P53 (TP53) is the most studied tumor suppressor. This article breaks down its domain architecture, stress-activation mechanism, hotspot mutation spectrum, and the functional readouts and experimental interfaces commonly used in tumor research.